NDC 70121-1653-01 - Triamcinolone Acetonide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70121-1653
- Requested NDC
- 70121-1653-01
- Package NDCs from labels
- 70121-1653-1, 70121-1653-01
- Manufacturer
- Amneal Pharmaceuticals LLC
- Effective date
- 2026-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamcinolone Acetonide - Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals LLC | 2026-06-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70121-1653-1 | Triamcinolone Acetonide | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SUSPENSION | 10 | 7 | |
| 70121-1653-1 | Triamcinolone Acetonide | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70121-1653 | TRIAMCINOLONE ACETONIDE INJECTION, SUSPENSION [AMNEAL PHARMACEUTICALS LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241122_bf0b4d32-c8b7-48c9-a29b-3e7c2afc6cbf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70121-1653-1 | ML - Milliliter | 70121-1653 | 898f4da9-c517-42af-b1c4-52da2f770d6f | 1 | 2019-05-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Redpharm Drug | 5e42871a-5ead-4dbf-e063-6394a90afeed | 2026-10-20 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals, Inc. | a1633e66-2ce8-42e4-8046-ac10dadfa34b | 2026-10-19 | Adverse reactions | F446C597KA |
| Triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc. | 777c3cb9-da2b-431c-934f-f3c70f93d6cb | 2026-10-19 | Adverse reactions | F446C597KA |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-10-16 | Warnings | 6OZP39ZG8H |
| TheraTears Extra | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | MEDTECH PRODUCTS INC | 77f504c1-b8e0-4371-ac3e-9d453d84714b | 2026-10-15 | Warnings | K679OBS311 |
| TheraTears Extra | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED | MEDTECH PRODUCTS INC | f1845041-9d8d-42a0-a2cb-68def7a5aac7 | 2026-10-15 | Warnings | K679OBS311 |
| TheraTears Lubricant | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 797b0394-2f0f-4733-8d20-ec5bdf3e085d | 2026-10-15 | Warnings | K679OBS311 |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| triamcinolone acetonide | TRIAMCINOLONE ACETONIDE | Preferred Pharmaceuticals Inc. | 5701a07f-bd22-4bc7-95ff-0c5444ea5971 | 2026-10-12 | Adverse reactions | F446C597KA |
| nasal allergy | TRIAMCINOLONE ACETONIDE | Kroger Company | b5f3bb98-4eb5-4c25-ae90-e2aa9ff5667d | 2026-10-09 | Warnings | F446C597KA |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| VitaPhyte Lubricant Eye Drops | LUBRICANT EYE DROPS | Guangzhou Liyan Cosmetics Technology Co., Ltd. | 5d39f7b1-c0ed-33dc-e063-6394a90aee31 | 2026-10-07 | Warnings | K679OBS311 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.